Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-005391-29Phase 4Completed
Phase 4 trial of Bronchitol in end-stage kidney disease (ESKD) and kidney transplant, sponsored by Medical University of Vienna. Primary endpoint: Biomarker panel (xMAP Luminex multi-analyte profiling). Started Jun 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-005391-29.